DNA Methylation in the Pathogenesis of Autoimmunity
Xueqing Xu,Ping Yang,Zhang Shu,Yun Bai,Cong-Yi Wang
DOI: https://doi.org/10.1002/9780470933947.ch3
2011-01-01
Abstract:Chapter 3 DNA Methylation in the Pathogenesis of Autoimmunity Xueqing Xu, Xueqing Xu Department of Medical Genetics, Third Military Medical University, Chongqing, ChinaSearch for more papers by this authorPing Yang, Ping Yang The Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaSearch for more papers by this authorZhang Shu, Zhang Shu The Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaSearch for more papers by this authorYun Bai, Yun Bai Department of Medical Genetics, Third Military Medical University, Chongqing, ChinaSearch for more papers by this authorCong-Yi Wang, Cong-Yi Wang The Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China Center for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta, GA, USASearch for more papers by this author Xueqing Xu, Xueqing Xu Department of Medical Genetics, Third Military Medical University, Chongqing, ChinaSearch for more papers by this authorPing Yang, Ping Yang The Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaSearch for more papers by this authorZhang Shu, Zhang Shu The Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaSearch for more papers by this authorYun Bai, Yun Bai Department of Medical Genetics, Third Military Medical University, Chongqing, ChinaSearch for more papers by this authorCong-Yi Wang, Cong-Yi Wang The Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China Center for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta, GA, USASearch for more papers by this author Book Editor(s):Weikuan Gu, Weikuan Gu Department of Orthopedic Surgery—Campbell Clinic, University of Tennessee Health Science Center, Memphis, TN, USASearch for more papers by this authorYongjun Wang, Yongjun Wang Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaSearch for more papers by this author First published: 21 March 2011 https://doi.org/10.1002/9780470933947.ch3 AboutPDFPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShareShare a linkShare onEmailFacebookTwitterLinkedInRedditWechat Summary This chapter contains sections titled: Introduction General Information for DNA Methylation in Mammals DNA Methyltransferases and Methyl-CpG-Binding Domain (MBD) Proteins DNA Methylation in T and B Cell Development The Implication of DNA Methylation in Autoimmune Diseases Common Technological Approaches for Assay of DNA Methylation Summary Acknowledgments References REFERENCES Aggarwal BB, Shishodia S. (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71: 1397–421. 10.1016/j.bcp.2006.02.009 CASPubMedWeb of Science®Google Scholar Alonzi T, Fattori E, Lazzaro D, Costa P, Probert L, Kollias G, De Benedetti F, Poli V, Ciliberto G. (1998). Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med 187: 461–68. 10.1084/jem.187.4.461 CASPubMedWeb of Science®Google Scholar Amaravadi L, Klemsz MJ. (1999). DNA methylation and chromatin structure regulate PU.1 expression. DNA Cell Biol 18: 875–84. 10.1089/104454999314737 CASPubMedWeb of Science®Google Scholar Amir RE, Van DV, Wan M, Tran CQ, Francke U, Zoghbi HY. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185–88. 10.1038/13810 CASPubMedWeb of Science®Google Scholar Andersen AA, Panning B. (2003). Epigenetic gene regulation by noncoding RNAs. Curr Opin Cell Biol 15: 281–89. 10.1016/S0955-0674(03)00041-3 CASPubMedWeb of Science®Google Scholar Ariel M. (2001). A PCR-based method for studying DNA methylation. Methods Mol Biol 181: 205–16. CASPubMedGoogle Scholar Atkinson MA. (2005). ADA Outstanding Scientific Achievement Lecture 2004. Thirty years of investigating the autoimmune basis for type 1 diabetes: why can't we prevent or reverse this disease? Diabetes 54: 1253–63. 10.2337/diabetes.54.5.1253 CASPubMedWeb of Science®Google Scholar Ballestar E, Esteller M, Richardson BC. (2006). The epigenetic face of systemic lupus erythematosus. J Immunol 176: 7143–47. 10.4049/jimmunol.176.12.7143 CASPubMedWeb of Science®Google Scholar Ballestar E, Pile LA, Wassarman DA, Wolffe AP, Wade PA. (2001). A Drosophila MBD family member is a transcriptional corepressor associated with specific genes. Eur J Biochem 268: 5397–406. 10.1046/j.0014-2956.2001.02480.x CASPubMedWeb of Science®Google Scholar Baron U, Floess S, Wieczorek G, Baumann K, Grutzkau A, Dong J, Thiel A, Boeld TJ, Hoffmann P, Edinger M, Turbachova I, Hamann A, Olek S, Huehn J. (2007). DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated Foxp3(+) conventional T cells. Eur J Immunol 37: 2378–89. 10.1002/eji.200737594 CASPubMedWeb of Science®Google Scholar Bestor TH, Ingram VM. (1983). Two DNA methyltransferases from murine erythroleukemia cells: purification, sequence specificity, and mode of interaction with DNA. Proc Natl Acad Sci U S A 80: 5559–63. 10.1073/pnas.80.18.5559 CASPubMedWeb of Science®Google Scholar Bettini M, Vignali DA. (2009). Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol 21: 612–18. 10.1016/j.coi.2009.09.011 CASPubMedWeb of Science®Google Scholar Bird AP, Wolffe AP. (1999). Methylation-induced repression — belts, braces, and chromatin. Cell 99: 451–54. 10.1016/S0092-8674(00)81532-9 CASPubMedWeb of Science®Google Scholar Bix M, Locksley RM. (1998). Independent and epigenetic regulation of the interleukin-4 alleles in CD4 + T cells. Science 281: 1352–54. 10.1126/science.281.5381.1352 CASPubMedWeb of Science®Google Scholar Bombail V, Moggs JG, Orphanides G. (2004). Perturbation of epigenetic status by toxicants. Toxicol Lett 149: 51–58. 10.1016/j.toxlet.2004.01.003 CASPubMedWeb of Science®Google Scholar Bowen H, Kelly A, Lee T, Lavender P. (2008). Control of cytokine gene transcription in Th1 and Th2 cells. Clin Exp Allergy 38: 1422–31. 10.1111/j.1365-2222.2008.03067.x CASPubMedWeb of Science®Google Scholar Brenner C, Fuks F. (2006). DNA methyltransferases: facts, clues, mysteries. Curr Top Microbiol Immunol 301: 45–66. 10.1007/3-540-31390-7_3 CASPubMedWeb of Science®Google Scholar Bruniquel D, Schwartz RH. (2003). Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol 4: 235–40. 10.1038/ni887 CASPubMedWeb of Science®Google Scholar Callinan PA, Feinberg AP. (2006). The emerging science of epigenomics. Hum Mol Genet 15 (Spec. no 1): R95–101. 10.1093/hmg/ddl095 CASPubMedWeb of Science®Google Scholar Chappell C, Beard C, Altman J, Jaenisch R, Jacob J. (2006). DNA methylation by DNA methyltransferase 1 is critical for effector CD8 T cell expansion. J Immunol 176: 4562–72. 10.4049/jimmunol.176.8.4562 CASPubMedWeb of Science®Google Scholar Cheng LC, Tavazoie M, Doetsch F. (2005). Stem cells: from epigenetics to microRNAs. Neuron 46: 363–67. 10.1016/j.neuron.2005.04.027 CASPubMedWeb of Science®Google Scholar Dahlquist G. (1998). The aetiology of type 1 diabetes: an epidemiological perspective. Acta Paediatr Suppl 425: 5–10. 10.1111/j.1651-2227.1998.tb01244.x CASPubMedWeb of Science®Google Scholar Danbara M, Kameyama K, Higashihara M, Takagaki Y. (2002). DNA methylation dominates transcriptional silencing of PAX5 in terminally differentiated B cell lines. Mol Immunol 38: 1161–66. 10.1016/S0161-5890(02)00003-2 CASPubMedWeb of Science®Google Scholar Deng C, Lu Q, Zhang Z, Rao T, Attwood J, Yung R, Richardson B. (2003). Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum 48: 746–56. 10.1002/art.10833 CASPubMedWeb of Science®Google Scholar Dennis C. (2003). Epigenetics and disease: altered states. Nature 421: 686–88. 10.1038/421686a CASPubMedWeb of Science®Google Scholar Dolinoy DC, Weidman JR, Jirtle RL. (2006). Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod Toxicol 23: 297–307. 10.1016/j.reprotox.2006.08.012 CASPubMedWeb of Science®Google Scholar Dubroff LM, Reid RJ Jr. (1980). Hydralazine-pyrimidine interactions may explain hydralazine-induced lupus erythematosus. Science 208: 404–06. 10.1126/science.7367866 CASPubMedWeb of Science®Google Scholar Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW. (2000). MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28: E32. 10.1002/jcb.10464 CASPubMedWeb of Science®Google Scholar Egger G, Liang G, Aparicio A, Jones PA. (2004). Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457–63. 10.1038/nature02625 CASPubMedWeb of Science®Google Scholar Ehrlich M, Jackson K, Weemaes C. (2006). Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF). Orphanet J Rare Dis 1: 2. 10.1186/1750-1172-1-2 PubMedWeb of Science®Google Scholar Eisenstein EM, Williams CB. (2009). The T(reg)/Th17 cell balance: a new paradigm for autoimmunity. Pediatr Res 65: 26R–31R. 10.1203/PDR.0b013e31819e76c7 CASPubMedWeb of Science®Google Scholar Eivazova ER, Aune TM. (2004). Dynamic alterations in the conformation of the IFNγgene region during T helper cell differentiation. Proc Natl Acad Sci U S A 101: 251–56. 10.1073/pnas.0303919101 CASPubMedWeb of Science®Google Scholar Esteller M. (2006). The necessity of a human epigenome project. Carcinogenesis 27: 1121–25. 10.1093/carcin/bgl033 CASPubMedWeb of Science®Google Scholar Fatemi M, Hermann A, Gowher H, Jeltsch A. (2002). DNMT3a and Dnmt1 functionally cooperate during de novo methylation of DNA. Eur J Biochem 269: 4981–84. 10.1046/j.1432-1033.2002.03198.x CASPubMedWeb of Science®Google Scholar Fatemi M, Wade PA. (2006). MBD family proteins: reading the epigenetic code. J Cell Sci 119: 3033–37. 10.1242/jcs.03099 CASPubMedWeb of Science®Google Scholar Fields PE, Lee GR, Kim ST, Bartsevich VV, Flavell RA. (2004). Th2-specific chromatin remodeling and enhancer activity in the Th2 cytokine locus control region. Immunity 21: 865–76. 10.1016/j.immuni.2004.10.015 CASPubMedWeb of Science®Google Scholar Filippi CM, von Herrath MG. (2008). Viral trigger for type 1 diabetes: pros and cons. Diabetes 57: 2863–71. 10.2337/db07-1023 CASPubMedWeb of Science®Google Scholar Fischle W, Wang Y, Allis CD. (2003). Histone and chromatin cross-talk. Curr Opin Cell Biol 15: 172–83. 10.1016/S0955-0674(03)00013-9 CASPubMedWeb of Science®Google Scholar Fitzpatrick DR, Shirley KM, Kelso A. (1999). Cutting edge: stable epigenetic inheritance of regional IFN-gamma promoter demethylation in CD44highCD8 + T lymphocytes. J Immunol 162: 5053–57. CASPubMedWeb of Science®Google Scholar Fitzpatrick DR, Wilson CB. (2003). Methylation and demethylation in the regulation of genes, cells, and responses in the immune system. Clin Immunol 109: 37–45. 10.1016/S1521-6616(03)00205-5 CASPubMedWeb of Science®Google Scholar Floess S, Freyer J, Siewert C, Baron U, Olek S, Polansky J, Schlawe K, Chang HD, Bopp T, Schmitt E, Klein-Hessling S, Serfling E, Hamann A, Huehn J. (2007). Epigenetic control of the Foxp3 locus in regulatory T cells. PLoS Biol 5: e38. 10.1371/journal.pbio.0050038 CASPubMedWeb of Science®Google Scholar Fodor SP, Read JL, Pirrung MC, Stryer L, Lu AT, Solas D. (1991). Light-directed, spatially addressable parallel chemical synthesis. Science 251: 767–73. 10.1126/science.1990438 CASPubMedWeb of Science®Google Scholar Fraga MF, Ballestar E, Montoya G, Taysavang P, Wade PA, Esteller M. (2003). The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res 31: 1765–74. 10.1093/nar/gkg249 CASPubMedWeb of Science®Google Scholar Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, Heine-Suner D, Cigudosa JC, Urioste M, Benitez J, Boix-Chornet M, Sanchez-Aguilera A, Ling C, Carlsson E, Poulsen P, Vaag A, Stephan Z, Spector TD, Wu YZ, Plass C, Esteller M. (2005). Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 102: 10604–09. 10.1073/pnas.0500398102 CASPubMedWeb of Science®Google Scholar Frigola J, Ribas M, Risques RA, Peinado MA. (2002). Methylome profiling of cancer cells by amplification of inter-methylated sites (AIMS). Nucleic Acids Res 30: e28. 10.1093/nar/30.7.e28 PubMedWeb of Science®Google Scholar Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL. (1992). A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 89: 1827–31. 10.1073/pnas.89.5.1827 CASPubMedWeb of Science®Google Scholar Fu S, Zhang N, Yopp AC, Chen D, Mao M, Chen D, Zhang H, Ding Y, Bromberg JS. (2004). TGF-beta induces Foxp3 + T -regulatory cells from CD4 + C. Am J Transplant 4: 1614–27. 10.1111/j.1600-6143.2004.00566.x CASPubMedWeb of Science®Google Scholar Fuks F. (2005). DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 15: 490–95. 10.1016/j.gde.2005.08.002 CASPubMedWeb of Science®Google Scholar Fulda S, Kufer MU, Meyer E, van Valen F, Dockhorn-Dworniczak B, Debatin KM. (2001). Sensitization for death receptor-or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 20: 5865–77. 10.1038/sj.onc.1204750 CASPubMedWeb of Science®Google Scholar Goll MG, Kirpekar F, Maggert KA, Yoder JA, Hsieh CL, Zhang X, Golic KG, Jacobsen SE, Bestor TH. (2006). Methylation of tRNAAsp by the DNA methyltransferase homolog DNMT2. Science 311: 395–98. 10.1126/science.1120976 CASPubMedWeb of Science®Google Scholar Gonzalgo ML, Liang G, Spruck CH III, Zingg JM, Rideout WM III, Jones PA. (1997). Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res 57: 594–99. CASPubMedWeb of Science®Google Scholar Gopisetty G, Ramachandran K, Singal R. (2006). DNA methylation and apoptosis. Mol Immunol 43: 1729–40. 10.1016/j.molimm.2005.11.010 CASPubMedWeb of Science®Google Scholar Goyal R, Reinhardt R, Jeltsch A. (2006). Accuracy of DNA methylation pattern preservation by the DNMT1 methyltransferase. Nucleic Acids Res 34: 1182–88. 10.1093/nar/gkl002 CASPubMedWeb of Science®Google Scholar Grogan JL, Mohrs M, Harmon B, Lacy DA, Sedat JW, Locksley RM. (2001). Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14: 205–15. 10.1016/S1074-7613(01)00103-0 CASPubMedWeb of Science®Google Scholar Hansen RS, Wijmenga C, Luo P, Stanek AM, Canfield TK, Weemaes CM, Gartler SM. (1999). The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc Natl Acad Sci U S A 96: 14412–17. 10.1073/pnas.96.25.14412 CASPubMedWeb of Science®Google Scholar Hatton RD, Harrington LE, Luther RJ, Wakefield T, Janowski KM, Oliver JR, Lallone RL, Murphy KM, Weaver CT. (2006). A distal conserved sequence element controls Ifng gene expression by T cells and NK cells. Immunity 25: 717–29. 10.1016/j.immuni.2006.09.007 CASPubMedWeb of Science®Google Scholar Hayashi H, Nagae G, Tsutsumi S, Kaneshiro K, Kozaki T, Kaneda A, Sugisaki H, Aburatani H. (2007). High-resolution mapping of DNA methylation in human genome using oligonucleotide tiling array. Hum Genet 120: 701–11. 10.1007/s00439-006-0254-6 CASPubMedWeb of Science®Google Scholar Heller G, Zielinski CC, Zochbauer-Muller S. (2010). Lung cancer: from single-gene methylation to methylome profiling. Cancer Metastasis Rev 29 (1): 95–107. 10.1007/s10555-010-9203-x CASPubMedWeb of Science®Google Scholar Hendrich B, Abbott C, McQueen H, Chambers D, Cross S, Bird A. (1999). Genomic structure and chromosomal mapping of the murine and human MBD1, MBD2, MBD3, and MBD4 genes. Mamm Genome 10: 906–12. 10.1007/s003359901112 CASPubMedWeb of Science®Google Scholar Hendrich B, Bird A. (1998). Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 18: 6538–47. 10.1128/MCB.18.11.6538 CASPubMedWeb of Science®Google Scholar Hendrich B, Guy J, Ramsahoye B, Wilson VA, Bird A. (2001). Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev 15: 710–23. 10.1101/gad.194101 CASPubMedWeb of Science®Google Scholar Hendrich B, Tweedie S. (2003). The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends Genet 19: 269–77. 10.1016/S0168-9525(03)00080-5 CASPubMedWeb of Science®Google Scholar Henikoff S, Furuyama T, Ahmad K. (2004). Histone variants, nucleosome assembly and epigenetic inheritance. Trends Genet 20: 320–26. 10.1016/j.tig.2004.05.004 CASPubMedWeb of Science®Google Scholar Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. (1996). Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93: 9821–26. 10.1073/pnas.93.18.9821 CASPubMedWeb of Science®Google Scholar Hodge DR, Xiao W, Clausen PA, Heidecker G, Szyf M, Farrar WL. (2001). Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells. J Biol Chem 276: 39508–11. 10.1074/jbc.C100343200 CASPubMedWeb of Science®Google Scholar Hofstetter H, Gold R, Hartung HP. (2009). Th17 cells in MS and experimental autoimmune encephalomyelitis. Int MS J 16: 12–18. PubMedGoogle Scholar Holliday R. (2006). Dual inheritance. Curr Top Microbiol Immunol 301: 243–56. 10.1007/3-540-31390-7_9 CASPubMedWeb of Science®Google Scholar Hutchins AS, Artis D, Hendrich BD, Bird AP, Scott P, Reiner SL. (2005). Cutting edge: a critical role for gene silencing in preventing excessive type 1 immunity. J Immunol 175: 5606–10. 10.4049/jimmunol.175.9.5606 CASPubMedWeb of Science®Google Scholar Hutchins AS, Mullen AC, Lee HW, Sykes KJ, High FA, Hendrich BD, Bird AP, Reiner SL. (2002). Gene silencing quantitatively controls the function of a developmental trans-activator. Mol Cell 10: 81–91. 10.1016/S1097-2765(02)00564-6 CASPubMedWeb of Science®Google Scholar Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR. (2006). The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17 + T helper cells. Cell 126: 1121–33. 10.1016/j.cell.2006.07.035 CASPubMedWeb of Science®Google Scholar Janson PC, Winerdal ME, Marits P, Thorn M, Ohlsson R, Winqvist O. (2008). Foxp3 promoter demethylation reveals the committed Treg population in humans. PLoS One 3: e1612. 10.1371/journal.pone.0001612 CASPubMedWeb of Science®Google Scholar Jeltsch A, Walter J, Reinhardt R, Platzer M. (2006). German human methylome project started. Cancer Res 66: 73–78. 10.1158/0008-5472.CAN-06-1071 Web of Science®Google Scholar Jones B, Chen J. (2006). Inhibition of IFN-gamma transcription by site-specific methylation during T helper cell development. EMBO J 25: 2443–52. 10.1038/sj.emboj.7601148 CASPubMedWeb of Science®Google Scholar Jones PA, Martienssen R. (2005). A blueprint for a Human Epigenome Project: the AACR Human Epigenome Workshop. Cancer Res 65: 11241–46. 10.1158/0008-5472.CAN-05-3865 CASPubMedWeb of Science®Google Scholar Junien C, Gallou-Kabani C, Vige A, Gross MS. (2005). [Nutritionnal epigenomics: consequences of unbalanced diets on epigenetics processes of programming during lifespan and between generations]. Ann Endocrinol (Paris) 66: 2S19–28. CASPubMedGoogle Scholar Kaplan MJ, Lu Q, Wu A, Attwood J, Richardson B. (2004). Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4 + lupus T cells. J Immunol 172: 3652–61. 10.4049/jimmunol.172.6.3652 CASPubMedWeb of Science®Google Scholar Karouzakis E, Gay RE, Michel BA, Gay S, Neidhart M. (2009). DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 60: 3613–22. 10.1002/art.25018 CASPubMedWeb of Science®Google Scholar Kim HP, Leonard WJ. (2007). CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med 204: 1543–51. 10.1084/jem.20070109 CASPubMedWeb of Science®Google Scholar Knip M, Veijola R, Virtanen SM, Hyoty H, Vaarala O, Akerblom HK. (2005). Environmental triggers and determinants of type 1 diabetes. Diabetes 54 (Suppl 2): S125–36. 10.2337/diabetes.54.suppl_2.S125 CASPubMedWeb of Science®Google Scholar Komatsu N, Mariotti-Ferrandiz ME, Wang Y, Malissen B, Waldmann H, Hori S. (2009). Heterogeneity of natural Foxp3 + T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci U S A 106: 1903–08. 10.1073/pnas.0811556106 CASPubMedWeb of Science®Google Scholar Korb A, Pavenstadt H, Pap T. (2009). Cell death in rheumatoid arthritis. Apoptosis 14: 447–54. 10.1007/s10495-009-0317-y PubMedWeb of Science®Google Scholar Koturbash I, Baker M, Loree J, Kutanzi K, Hudson D, Pogribny I, Sedelnikova O, Bonner W, Kovalchuk O. (2006a). Epigenetic dysregulation underlies radiation-induced transgenerational genome instability in vivo. Int J Radiat Oncol Biol Phys 66: 327–30. 10.1016/j.ijrobp.2006.06.012 CASPubMedWeb of Science®Google Scholar Koturbash I, Rugo RE, Hendricks CA, Loree J, Thibault B, Kutanzi K, Pogribny I, Yanch JC, Engelward BP, Kovalchuk O. (2006b). Irradiation induces DNA damage and modulates epigenetic effectors in distant bystander tissue in vivo. Oncogene 25: 4267–75. 10.1038/sj.onc.1209467 CASPubMedWeb of Science®Google Scholar Kouskouti A, Talianidis I. (2005). Histone modifications defining active genes persist after transcriptional and mitotic inactivation. EMBO J 24: 347–57. 10.1038/sj.emboj.7600516 CASPubMedWeb of Science®Google Scholar Lal G, Zhang N, van der Touw W, Ding Y, Ju W, Bottinger EP, Reid SP, Levy DE, Bromberg JS. (2009). Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol 182: 259–73. 10.4049/jimmunol.182.1.259 CASPubMedWeb of Science®Google Scholar Lee BH, Yegnasubramanian S, Lin X, Nelson WG. (2005). Procainamide is a specific inhibitor of DNA methyltransferase 1. J Biol Chem 280: 40749–56. 10.1074/jbc.M505593200 CASPubMedWeb of Science®Google Scholar Lee DU, Agarwal S, Rao A. (2002). Th2 lineage commitment and efficient IL-4 production involves extended demethylation of the IL-4 gene. Immunity 16: 649–60. 10.1016/S1074-7613(02)00314-X CASPubMedWeb of Science®Google Scholar Leonhardt H, Page AW, Weier HU, Bestor TH. (1992). A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell 71: 865–73. 10.1016/0092-8674(92)90561-P CASPubMedWeb of Science®Google Scholar Li HP, Leu YW, Chang YS. (2005a). Epigenetic changes in virus-associated human cancers. Cell Res 15: 262–71. 10.1038/sj.cr.7290295 CASPubMedWeb of Science®Google Scholar Li JZ, Steinman CR. (1989). Plasma DNA in systemic lupus erythematosus. Characterization of cloned base sequences. Arthritis Rheum 32: 726–33. 10.1002/anr.1780320610 CASPubMedWeb of Science®Google Scholar Li M, Guo D, Isales CM, Eizirik DL, Atkinson M, She JX, Wang CY. (2005b). Sumo wrestling with type 1 diabetes. J Mol Med 83: 504–13. 10.1007/s00109-005-0645-5 CASPubMedWeb of Science®Google Scholar Liu L, Wylie RC, Andrews LG, Tollefsbol TO. (2003). Aging, cancer and nutrition: the DNA methylation connection. Mech Ageing Dev 124: 989–98. 10.1016/j.mad.2003.08.001 CASPubMedWeb of Science®Google Scholar Luo X, Zhang Q, Liu V, Xia Z, Pothoven KL, Lee C. (2008). Cutting edge: TGF-beta-induced expression of Foxp3 in T cells is mediated through inactivation of ERK. J Immunol 180: 2757–61. 10.4049/jimmunol.180.5.2757 CASPubMedWeb of Science®Google Scholar Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, Sugimura T, Ichinose M, Ushijima T. (2006). High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 12: 989–95. 10.1158/1078-0432.CCR-05-2096 CASPubMedWeb of Science®Google Scholar Maier H, Colbert J, Fitzsimmons D, Clark DR, Hagman J. (2003). Activation of the early B-cell-specific MB-1 (IG-alpha) gene by Pax-5 is dependent on an unmethylated ETS binding site. Mol Cell Biol 23: 1946–60. 10.1128/MCB.23.6.1946-1960.2003 CASPubMedWeb of Science®Google Scholar Makar KW, Perez-Melgosa M, Shnyreva M, Weaver WM, Fitzpatrick DR, Wilson CB. (2003). Active recruitment of DNA methyltransferases regulates interleukin 4 in thymocytes and T cells. Nat Immunol 4: 1183–90. 10.1038/ni1004 CASPubMedWeb of Science®Google Scholar Makar KW, Wilson CB. (2004). DNA methylation is a nonredundant repressor of the Th2 effector program. J Immunol 173: 4402–06. 10.4049/jimmunol.173.7.4402 CASPubMedWeb of Science®Google Scholar Mattick JS. (2001). Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep 2: 986–91. 10.1093/embo-reports/kve230 CASPubMedWeb of Science®Google Scholar Mazari L, Ouarzane M, Zouali M. (2007). Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus. Proc Natl Acad Sci U S A 104: 6317–22. 10.1073/pnas.0610434104 CASPubMedWeb of Science®Google Scholar Meaney MJ, Szyf M. (2005). Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues Clin Neurosci 7: 103–23. 10.31887/DCNS.2005.7.2/mmeaney PubMedGoogle Scholar Meehan RR, Lewis JD, Bird AP. (1992). Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res 20: 5085–92. 10.1093/nar/20.19.5085 CASPubMedWeb of Science®Google Scholar Metcalfe KA, Hitman GA, Rowe RE, Hawa M, Huang X, Stewart T, Leslie RD. (2001). Concordance for type 1 diabetes in identical twins is affected by insulin genotype. Diabetes Care 24: 838–42. 10.2337/diacare.24.5.838 CASPubMedWeb of Science®Google Scholar Millar CB, Guy J, Sansom OJ, Selfridge J, MacDougall E, Hendrich B, Keightley PD, Bishop SM, Clarke AR, Bird A. (2002). Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. Science 297: 403–05. 10.1126/science.1073354 CASPubMedWeb of Science®Google Scholar Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S. (2009). Functional delineation and differentiation dynamics of human CD4 + T cells expressing the FoxP3 transcription factor. Immunity 30: 899–911. 10.1016/j.immuni.2009.03.019 CASPubMedWeb of Science®Google Scholar Moon C, Kim SH, Park KS, Choi BK, Lee HS, Park JB, Choi GS, Kwan JH, Joh JW, Kim SJ. (2009). Use of epigenetic modification to induce Foxp3 expression in naive T cells. Transplant Proc 41: 1848–54. 10.1016/j.transproceed.2009.02.101 CASPubMedWeb of Science®Google Scholar Morgan HD, Sutherland HG, Martin DI, Whitelaw E. (1999). Epigenetic inheritance at the agouti locus in the mouse. Nat Genet 23: 314–18. 10.1038/15490 CASPubMedWeb of Science®Google Scholar Natoli G, Saccani S, Bosisio D, Marazzi I. (2005). Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat Immunol 6: 439–45. 10.1038/ni1196 CASPubMedWeb of Science®Google Scholar Neidhart M, Rethage J, Kuchen S, Kunzler P, Crowl RM, Billingham ME, Gay RE, Gay S. (2000). Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthriti
What problem does this paper attempt to address?
-
Advances in Research on Relationship Between DNA Hypomethylation and Systemic Lupus Erythematosus
Zun-zhong Li,Min Zheng
DOI: https://doi.org/10.3785/j.issn.1008-9292.2006.04.021
2006-01-01
Abstract:T-cell DNA hypomethylation can increase expression of genes that have potential relation to autoimmunity. CD70 overexpression may be associated with B-cell activation and immunoglobulin secretion, while perforin plays an important role in T-cell-mediated macrophage apoptosis. DNA hypomethylation can activate human endogenous retroviruses (HERV) sequences. Expression of HERV components may elicit autoantibodies production. Polyamines change structure of chromosome and interfere with DNA methylation process, which is involved in the pathogenesis of autoimmune diseases.
-
Methylation of T and B Lymphocytes in Autoimmune Rheumatic Diseases
Tiantian Deng,Zihan Wang,Qishun Geng,Zhaoran Wang,Yi Jiao,Wenya Diao,Jiahe Xu,Tingting Deng,Jing Luo,Qingwen Tao,Cheng Xiao
DOI: https://doi.org/10.1007/s12016-024-09003-4
2024-09-01
Clinical Reviews in Allergy & Immunology
Abstract:The role of abnormal epigenetic modifications, particularly DNA methylation, in the pathogenesis of autoimmune rheumatic diseases (ARDs) has garnered increasing attention. Lymphocyte dysfunction is a significant contributor to the pathogenesis of ARDs. Methylation is crucial for maintaining normal immune system function, and aberrant methylation can hinder lymphocyte differentiation, resulting in functional abnormalities that disrupt immune tolerance, leading to the excessive expression of inflammatory cytokines, thereby exacerbating the onset and progression of ARDs. Recent studies suggest that methylation-related factors have the potential to serve as biomarkers for monitoring the activity of ARDs. This review summarizes the current state of research on the impact of DNA and RNA methylation on the development, differentiation, and function of T and B cells and examines the progress of these epigenetic modifications in studies of six specific ARDs: systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, systemic sclerosis, juvenile idiopathic arthritis, and ankylosing spondylitis. Additionally, we propose that exploring the interplay between RNA methylation and DNA methylation may represent a novel direction for understanding the pathogenesis of ARDs and developing novel treatment strategies.
immunology,allergy
-
DNA Methylation of T Lymphocytes as a Therapeutic Target: Implications for Rheumatoid Arthritis Etiology
Jianan Zhao,Kai Wei,Cen Chang,Lingxia Xu,Ping Jiang,Shicheng Guo,Steven J. Schrodi,Dongyi He
DOI: https://doi.org/10.3389/fimmu.2022.863703
IF: 7.3
2022-01-01
Frontiers in Immunology
Abstract:Rheumatoid arthritis (RA) is an autoimmune disease that can cause joint damage and disability. Epigenetic variation, especially DNA methylation, has been shown to be involved in almost all the stages of the pathology of RA, from autoantibody production to various self-effector T cells and the defects of protective T cells that can lead to chronic inflammation and erosion of bones and joints. Given the critical role of T cells in the pathology of RA, the regulatory functions of DNA methylation in T cell biology remain unclear. In this review, we elaborate on the relationship between RA pathogenesis and DNA methylation in the context of different T cell populations. We summarize the relevant methylation events in T cell development, differentiation, and T cell-related genes in disease prediction and drug efficacy. Understanding the epigenetic regulation of T cells has the potential to profoundly translate preclinical results into clinical practice and provide a framework for the development of novel, individualized RA therapeutics.
-
Mechanisms of DNA Methylation Control and Epigenome Engineering
Wanlu Liu
2018-01-01
Abstract:Author(s): Liu, Wanlu | Advisor(s): Jacobsen, Steven E | Abstract: Cytosine DNA methylation is an evolutionarily conserved epigenetic mark that plays critical roles in diverse biological processes, including gene and transposon silencing and imprinting. In mammals, DNA methylation mostly occurs in the symmetric dinucleotide CG sites. In the model plant Arabidopsis thaliana, DNA methylation frequently occurs at cytosine bases in all sequence contexts (CG, CHG and CHH, where H represents A, C or T). In Arabidopsis, de novo DNA methylation is established by a process known as RNA-directed DNA methylation (RdDM). RdDM in plants not only requires the upstream production of 24-nucleotide (nt) small interfering RNAs (siRNAs) and the downstream recruitment of de novo DNA methyltransferase DOMAINS REARRANGED METHYLTRANSFERASE 2 (DRM2), the production of RNA polymerase V (Pol V)-dependent intergenic non-coding (IGN) transcripts plays a crucial role likely in serving as scaffolds for siRNAs binding. Pol V is required for DNA methylation and gene silencing and has been shown to be transcriptionally active in vitro. However, the characteristics of Pol V transcripts is poorly understood probably due to its low abundance. In this dissertation, to better understand the features of Pol V transcripts in vivo, I will first describe the application of a technique modified from global nuclear run-on (GRO) assay to characterize nascent Pol V transcripts at genome-wide level. With this technique, we captured Pol V nascent transcripts and we uncovered a novel mechanism of ARGONAUTE4/6/9 (AGO4/6/9) dependent, small-RNA-guided co-transcriptional slicing of nascent Pol V transcripts. With the fast development of genome editing recent years, epigenetic modification including targeted DNA methylation and demethylation also becomes attractive for its capability of stably regulate gene expression. In order to develop site-specific and efficient tools for DNA methylation targeting, we tethered artificial zinc finger protein recognizing specific DNA sequence to various RdDM proteins (ZF-RdDM) in Arabidopsis. With this tool, we studied the hierarchy of action within RdDM pathway by testing their ability to target methylation in different mutant backgrounds. Also, at thousands of ZF-RdDM off target sites, we characterized the ectopic siRNAs production, Pol V recruitment and DNA methylation establishment and found that simultaneously recruiting both arms of the RdDM pathway, siRNA biogenesis and Pol V recruitment, dramatically enhanced targeted methylation. We then also developed a tool to target DNA demethylation in plants by fusing the catalytic domain of the human demethylase TEN-ELEVEN TRANSLOCATION1 (TET1cd) and an artificial zinc finger protein or CRISPR/dCas9 system. Finally, I will discuss DNA methylation landscape in human embryonic stem cells (hESCs). hESCs are morphologically and transcriptionally similar to stem cells derived from the mouse post-implantation epiblast. Thus, hESCs are typically considered to exhibit ‘primed’ pluripotency. Various culture conditions have been developed to promote maintenance and self-renewal of hypomethylated ‘naive’ hESCs. We have discovered that reverting primed hESCs to naive hESCs results in a Stage Specific Embryonic Antigen 4 (SSEA4)-negative population with a transcriptional program resembling the human pre-implantation epiblast. However, we also discovered that the methylation landscape of naive hESCs in vitro is distinct from human epiblast in vivo with a lost ‘memory’ of methylation state at primary imprints and human oocyte.
-
The immune factors driving DNA methylation variation in human blood
Jacob Bergstedt,Sadoune Ait Kaci Azzou,Kristin Tsuo,Anthony Jaquaniello,Alejandra Urrutia,Maxime Rotival,David T. S. Lin,Julia L. MacIsaac,Michael S. Kobor,Matthew L. Albert,Darragh Duffy,Etienne Patin,Lluís Quintana-Murci,Laurent Abel,Andres Alcover,Hugues Aschard,Philippe Bousso,Nollaig Bourke,Petter Brodin,Pierre Bruhns,Nadine Cerf-Bensussan,Ana Cumano,Christophe d’Enfert,Ludovic Deriano,Marie-Agnès Dillies,James Di Santo,Françoise Dromer,Gérard Eberl,Jost Enninga,Jacques Fellay,Ivo Gomperts-Boneca,Milena Hasan,Gunilla Karlsson Hedestam,Serge Hercberg,Molly A. Ingersoll,Olivier Lantz,Rose Anne Kenny,Mickaël Ménager,Frédérique Michel,Hugo Mouquet,Cliona O’Farrelly,Sandra Pellegrini,Antonio Rausell,Frédéric Rieux-Laucat,Lars Rogge,Magnus Fontes,Anavaj Sakuntabhai,Olivier Schwartz,Benno Schwikowski,Spencer Shorte,Frédéric Tangy,Antoine Toubert,Mathilde Touvier,Marie-Noëlle Ungeheuer,Christophe Zimmer,Lluis Quintana-Murci,
DOI: https://doi.org/10.1038/s41467-022-33511-6
IF: 16.6
2022-10-06
Nature Communications
Abstract:Abstract Epigenetic changes are required for normal development, yet the nature and respective contribution of factors that drive epigenetic variation in humans remain to be fully characterized. Here, we assessed how the blood DNA methylome of 884 adults is affected by DNA sequence variation, age, sex and 139 factors relating to life habits and immunity. Furthermore, we investigated whether these effects are mediated or not by changes in cellular composition, measured by deep immunophenotyping. We show that DNA methylation differs substantially between naïve and memory T cells, supporting the need for adjustment on these cell-types. By doing so, we find that latent cytomegalovirus infection drives DNA methylation variation and provide further support that the increased dispersion of DNA methylation with aging is due to epigenetic drift. Finally, our results indicate that cellular composition and DNA sequence variation are the strongest predictors of DNA methylation, highlighting critical factors for medical epigenomics studies.
multidisciplinary sciences
-
Highlights from the Latest Articles in Epigenomics
Biao Yan,Lan Ma
DOI: https://doi.org/10.2217/epi.13.85
2014-01-01
Epigenomics
Abstract:EpigenomicsVol. 6, No. 1 Research HighlightsHighlights from the latest articles in epigenomicsBiao Yan & Lan MaBiao YanPharmacology Research Center & the State Key Laboratory of Medical Neurobiology, School of Basic Medical Sciences & Institutes of Brain Science, Fudan University, 138 Yixueyuan Road, Shanghai 200032, China & Lan MaPharmacology Research Center & the State Key Laboratory of Medical Neurobiology, School of Basic Medical Sciences & Institutes of Brain Science, Fudan University, 138 Yixueyuan Road, Shanghai 200032, ChinaPublished Online:28 Feb 2014https://doi.org/10.2217/epi.13.85AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleReferences1 Peixoto L, Abel T. The role of histone acetylation in memory formation and cognitive impairments. Neuropsychopharmacology 38, 62–76 (2013).Crossref, Medline, CAS, Google Scholar2 Ito S, Shen L, Dai Q et al. Tet Proteins can convert 5-Methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333, 1300–1303 (2011).Crossref, Medline, CAS, Google Scholar3 He YF, Li BZ, Li Z et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333, 1303–1307 (2011).Crossref, Medline, CAS, Google Scholar4 Guo JU, Su Y, Zhong C et al. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 145, 423–434 (2011).Crossref, Medline, CAS, Google Scholar5 Kaas GA, Zhong C, Eason DE et al. TET1 controls CNS 5-methylcytosine hydroxylation, active DNA demethylation, gene transcription, and memory formation. Neuron 79, 1086–1093 (2013).Crossref, Medline, CAS, Google Scholar6 Zhang RR, Cui QY, Murai K et al. Tet1 regulates adult hippocampal neurogenesis and cognition. Cell Stem Cell 13, 237–245 (2013).Crossref, Medline, CAS, Google Scholar7 Rudenko A, Dawlaty MM, Seo J et al. Tet1 is critical for neuronal activity-regulated gene expression and memory extinction. Neuron 79, 1109–1122 (2013).Crossref, Medline, CAS, Google Scholar8 Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nat. Rev. Genet. 14, 204–220 (2013).Crossref, Medline, CAS, Google Scholar9 Zhang F, Cong L, Lodato S et al. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat. Biotechnol. 29, 149–153 (2011).Crossref, Medline, Google Scholar10 Konermann S, Brigham MD, Trevino AE et al. Optical control of mammalian endogenous transcription and epigenetic states. Nature 500, 472–476 (2013).Crossref, Medline, CAS, Google Scholar11 Maeder ML, Angstman JF, Richardson ME et al. Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nat. Biotechnol. 31(12), 1137–1142 (2013).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetails Vol. 6, No. 1 Follow us on social media for the latest updates Metrics Downloaded 87 times History Published online 28 February 2014 Published in print February 2014 Information© Future Medicine LtdFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download
-
Epigenetic Regulation of B Cells and Its Role in Autoimmune Pathogenesis
Fan Xiao,Ke Rui,Xiaofei Shi,Haijing Wu,Xiaoyan Cai,Kathy O. Lui,Qianjin Lu,Esteban Ballestar,Jie Tian,Hejian Zou,Liwei Lu
DOI: https://doi.org/10.1038/s41423-022-00933-7
2022-01-01
Abstract:B cells play a pivotal role in the pathogenesis of autoimmune diseases. Although previous studies have shown many genetic polymorphisms associated with B-cell activation in patients with various autoimmune disorders, progress in epigenetic research has revealed new mechanisms leading to B-cell hyperactivation. Epigenetic mechanisms, including those involving histone modifications, DNA methylation, and noncoding RNAs, regulate B-cell responses, and their dysregulation can contribute to the pathogenesis of autoimmune diseases. Patients with autoimmune diseases show epigenetic alterations that lead to the initiation and perpetuation of autoimmune inflammation. Moreover, many clinical and animal model studies have shown the promising potential of epigenetic therapies for patients. In this review, we present an up-to-date overview of epigenetic mechanisms with a focus on their roles in regulating functional B-cell subsets. Furthermore, we discuss epigenetic dysregulation in B cells and highlight its contribution to the development of autoimmune diseases. Based on clinical and preclinical evidence, we discuss novel epigenetic biomarkers and therapies for patients with autoimmune disorders.
-
Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis.
W Lei,Y Luo,W Lei,Y Luo,K Yan,S Zhao,Y Li,X Qiu,Y Zhou,H Long,M Zhao,Y Liang,Y Su,Q Lu
DOI: https://doi.org/10.1080/03009740902758875
2009-01-01
Scandinavian Journal of Rheumatology
Abstract:Objectives: T-cell DNA hypomethylation is thought to contribute to the development of systemic erythematosus lupus (SLE). However, it is unknown whether impaired T-cell DNA methylation occurs in other connective tissue diseases, such as systemic sclerosis (SSc) and dermatomyositis (DM). Methods: We quantified global methylation in CD4+ T cells from 12 healthy donors and patients with SLE, SSc, and DM (10 patients in each group). mRNA levels of DNA methyltransferases (DNMTs) and methyl-CpG-binding domain proteins (MBDs) were measured by reverse transcription polymerase chain reaction (RT-PCR). Results: CD4+ T-cell DNA from patients with SLE (both active and inactive) and SSc, but not DM, was significantly hypomethylated relative to controls. The average expression levels of DNMT1 and MBD4 mRNA were significantly lower whereas MBD2 and MeCP2 mRNA levels were significantly higher in the SLE group. DNMT1, MBD3, and MBD4 mRNA was significantly decreased in the SSc group, whereas MBD2 and MeCP2 mRNA was significantly higher in the DM group. The degree of global DNA hypomethylation correlated positively with the relative level of DNMT1 across SLE samples and MBD4 across the SSc samples. Conclusion: Reduced DNA methylation and abnormal expression of methylation-related genes in CD4+ T cells are associated with SLE and SSc.
-
Epigenetic Alterations in Cellular Immunity: New Insights into Autoimmune Diseases
Zijun Wang,Qianjin Lu,Zhihui Wang
DOI: https://doi.org/10.1159/000457944
2017-01-01
Cellular Physiology and Biochemistry
Abstract:Epigenetic modification is an additional regulator in immune responses as the genome-wide profiling somehow fails to explain the sophisticated mechanisms in autoimmune diseases. The effect of epigenetic modifications on adaptive immunity derives from their regulations to induce a permissive or negative gene expression. Epigenetic events, such as DNA methylation, histone modifications and microRNAs (miRNAs) are often found in T cell activation, differentiation and commitment which are the major parts in cellular immunity. Recognizing the complexity of interactions between epigenetic mechanisms and immune disturbance in autoimmune diseases is essential for the exploration of efficient therapeutic targets. In this review, we summarize a list of studies that indicate the significance of dysregulated epigenetic modifications in autoimmune diseases while focusing on T cell immunity.
-
Genome-Wide DNA Methylation Profiles Reveal Common Epigenetic Patterns of Interferon-Related Genes in Multiple Autoimmune Diseases
Sidi Chen,Weilin Pu,Shicheng Guo,Li Jin,Dongyi He,Jiucun Wang
DOI: https://doi.org/10.3389/fgene.2019.00223
IF: 3.7
2019-04-05
Frontiers in Genetics
Abstract:Graves' disease (GD), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) are complex autoimmune diseases sharing common clinical, genetic and pathogenetic features. However, the commonalities of the DNA methylation profiles for these diseases are still unknown. We conducted an integrative analysis of the multiple-autoimmune disease methylation dataset including GD, RA, SLE, and SSc samples, to identify the common methylation patterns of autoimmune diseases. We identified 15,289 differentially methylated sites between multiple-autoimmune disease patients and controls in CD4+ T cells. We found that the most significant differentially methylated sites had a remarkable enrichment in type I interferon (IFN) pathway genes. Similarly, we identified 9,295 differentially methylated sites between GD/SSc patients and controls in CD8+ T cells. The overall IFN-related gene panel annotated by gene ontology (GO) showed an excellent diagnostic capacity in CD4+ T cells (Sensitivity = 0.82, specificity = 0.82 and AUC = 0.90), while IFI44L, another IFN-related gene not annotated by GO, showed high prediction ability in both CD4+ (AUC = 0.86) and CD8+ (AUC = 0.75) T cells. In conclusion, our study demonstrated that hypomethylation of IFN-related genes is a common feature of GD/RA/SLE/SSc patients in CD4+ T cells, and the DNA methylation profile of IFN-related genes could be promising biomarkers for the diagnosis of GD, RA, SLE, and SSc.
genetics & heredity
-
The m6A methylation profiles of immune cells in type 1 diabetes mellitus
Yimeng Wang,Linling Xu,Shuoming Luo,Xiaoxiao Sun,Jiaqi Li,Haipeng Pang,Jun Zhou,Yuemin Zhou,Xiajie Shi,Xia Li,Gan Huang,Zhiguo Xie,Zhiguang Zhou
DOI: https://doi.org/10.3389/fimmu.2022.1030728
IF: 7.3
2022-11-15
Frontiers in Immunology
Abstract:Background Type 1 diabetes mellitus (T1DM) is caused by immune cell-mediated β-cell dysfunction. In recent decades, N6-methyladenosine (m6A) has attracted widespread attention in the scientific research field because it plays vital roles in the pathogenesis of immunity-related diseases, including autoimmune diseases. However, neither the m6A modification profile nor the potential role it plays in T1DM pathogenesis has been investigated to date. Materials and Methods An m6A mRNA epitranscriptomic microarray analysis was performed to analyze m6A regulator expression patterns and m6A methylation patterns in immune cells of T1DM patients (n=6) and healthy individuals (n=6). A bioinformatics analysis was subsequently performed to explore the potential biological functions and signaling pathways underlying T1DM pathogenesis. Furthermore, mRNA expression and m6A methylation levels were subsequently verified by qRT–PCR and methylated RNA immunoprecipitation–qPCR (MeRIP–qPCR), respectively, in the T1DM and healthy groups (n=6 per group). Results Among the multiple m6A regulators, METTL3 and IGF2BP2 had significantly downregulated expression, and YTHDC1 and HNRNPA2B1 had significantly upregulated expression in the T1DM group relative to the healthy group. The microarray analysis revealed 4247 differentially methylated transcripts, including 932 hypermethylated and 3315 hypomethylated transcripts, and 4264 differentially expressed transcripts, including 1818 upregulated transcripts and 2446 downregulated transcripts in the T1DM group relative to the healthy group. An association analysis between methylation and gene expression demonstrated that the expression of 590 hypermethylated transcripts was upregulated, and that of 1890 hypomethylated transcripts was downregulated. Pearson correlation analysis showed significant correlations between the expression levels of differentially expressed m6A regulators and the methylation levels of differentially methylated transcripts and significant correlations between the expression levels of differentially expressed m6A regulators and that of differentially expressed transcripts. Moreover, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses demonstrated that differentially methylated transcripts were involved in pathways related to immunity, including some closely associated with T1DM. Conclusions Our study presents m6A regulator expression patterns and m6A methylation patterns of immune cells in T1DM, showing that the m6A mark and m6A regulators are promising targets for T1DM diagnosis and treatment.
immunology
-
Myeloid-derived suppressor cell: A crucial player in autoimmune diseases
Dandan Xu,Cheng Li,Yushan Xu,Mingyue Huang,Dawei Cui,Jue Xie
DOI: https://doi.org/10.3389/fimmu.2022.1021612
IF: 7.3
2022-12-10
Frontiers in Immunology
Abstract:Myeloid-derived suppressor cells (MDSCs) are identified as a highly heterogeneous group of immature cells derived from bone marrow and play critical immunosuppressive functions in autoimmune diseases. Accumulating evidence indicates that the pathophysiology of autoimmune diseases was closely related to genetic mutations and epigenetic modifications, with the latter more common. Epigenetic modifications, which involve DNA methylation, covalent histone modification, and non-coding RNA-mediated regulation, refer to inheritable and potentially reversible changes in DNA and chromatin that regulate gene expression without altering the DNA sequence. Recently, numerous reports have shown that epigenetic modifications in MDSCs play important roles in the differentiation and development of MDSCs and their suppressive functions. The molecular mechanisms of differentiation and development of MDSCs and their regulatory roles in the initiation and progression of autoimmune diseases have been extensively studied, but the exact function of MDSCs remains controversial. Therefore, the biological and epigenetic regulation of MDSCs in autoimmune diseases still needs to be further characterized. This review provides a detailed summary of the current research on the regulatory roles of DNA methylation, histone modifications, and non-coding RNAs in the development and immunosuppressive activity of MDSCs, and further summarizes the distinct role of MDSCs in the pathogenesis of autoimmune diseases, in order to provide help for the diagnosis and treatment of diseases from the perspective of epigenetic regulation of MDSCs.
immunology
-
Methylation of Inflammatory Cells in Lung Diseases
Yifei Liu,Hongzhi Gao,Xiangdong Wang,Yiming Zeng
DOI: https://doi.org/10.1007/978-981-15-4494-1_5
2020-01-01
Advances in experimental medicine and biology
Abstract:This chapter overviews roles of DNA methylation in inflammatory cell biology with the focuses on lymphocytes and macrophages/monocytes in lung diseases, although the molecular mechanisms by which target genes are methylated and regulated in lung diseases remain unclear. Most of epigenetic studies on DNA methylation of target genes in lung diseases mainly demonstrated the correlation of DNA methylation of target genes with the levels of other corresponding factors, with the specificity of clinical phenomes, and with the severity of lung diseases. There is an urgent need to identify and validate the specificity and regulatory mechanisms of inflammatory cell epigenetics in depth. The epigenetic heterogeneity among different subsets of T cells and among promoters or non-promoters of target genes should be furthermore clarified in acute or chronic lung diseases and cancers. The hyper/hypo-methylation and modifications of chromosol and extrachromosomal DNA may result in alternations in proteins within inflammatory cells, which can be identified as disease-specific biomarkers and therapeutic targets.
-
Genome-Wide DNA Methylation Analysis in Systemic Sclerosis Reveals Hypomethylation of IFN-Associated Genes in CD4+ and CD8+ T Cells.
Weifeng Ding,Weilin Pu,Lei Wang,Shuai Jiang,Xiaodong Zhou,Wenzhen Tu,Ling Yu,Jiaqian Zhang,Shicheng Guo,Qingmei Liu,Yanyun Ma,Sidi Chen,Wenyu Wu,John Reveille,Hejian Zou,Li Jin,Jiucun Wang
DOI: https://doi.org/10.1016/j.jid.2017.12.003
IF: 7.59
2017-01-01
Journal of Investigative Dermatology
Abstract:Epigenetic modifications, including DNA methylation, play an important role in the pathogenesis of autoimmune diseases. In this study, we characterized the DNA methylome in primary T cells of patients with systemic sclerosis. Genome-wide DNA methylation assays of CD4(+) and CD8(+) T cells from 24 systemic sclerosis patients and 24 matched controls were conducted and differentially methylated regions were validated. In the discovery stage, we found that hypomethylation of genes involved in the type I IFN signaling pathway was significantly enriched in both CD4(+) (P = 7.59 x 10(-)6) and CD8(+) (P = 2.10 x 100(-8)) differentially methylated regions. In the validation stage, we confirmed these changes for five type I IFN-associated genes. In addition, protein levels of both type I IFN-alpha (P < 0.0001) and beta (P = 0.002) were significantly elevated in the sera of systemic sclerosis patients. Moreover, significant associations between type I IFN-alpha/beta protein levels with the DNA methylation status as well as the expression profiles of these IFN-associated genes were confirmed. In conclusion, the type I IFN pathway is dysfunctional at the epigenetic level in systemic sclerosis patients, indicating that hypomethylation and upregulation of type I IFN-associated genes might be critical in systemic sclerosis pathogenesis.
-
The effect of type 1 diabetes protection and susceptibility associated HLA class II genotypes on DNA methylation in immune cells
Sirpa Pahkuri,Shintaro Katayama,Milla Valta,Lucas Nygård,Mikael Knip,Juha Kere,Jorma Ilonen,Johanna Lempainen,the Finnish Pediatric Diabetes Register
DOI: https://doi.org/10.1111/tan.15548
2024-06-20
HLA
Abstract:The HLA region, especially HLA class I and II genes, which encode molecules for antigen presentation to T cells, plays a major role in the predisposition to autoimmune disorders. To clarify the mechanisms behind this association, we examined genome‐wide DNA methylation by microarrays to cover over 850,000 CpG sites in the CD4+ T cells and CD19+ B cells of healthy subjects homozygous either for DRB1*15‐DQA1*01‐DQB1*06:02 (DR2‐DQ6, n = 14), associated with a strongly decreased T1D risk, DRB1*03‐DQA1*05‐DQB1*02 (DR3‐DQ2, n = 19), or DRB1*04:01‐DQA1*03‐DQB1*03:02 (DR4‐DQ8, n = 17), associated with a moderately increased T1D risk. In total, we discovered 14 differentially methylated CpG probes, of which 10 were located in the HLA region and six in the HLA‐DRB1 locus. The main differences were between the protective genotype DR2‐DQ6 and the risk genotypes DR3‐DQ2 and DR4‐DQ8, where the DR2‐DQ6 group was hypomethylated compared to the other groups in all but four of the differentially methylated probes. The differences between the risk genotypes DR3‐DQ2 and DR4‐DQ8 were small. Our results indicate that HLA variants have few systemic effects on methylation and that their effect on autoimmunity is conveyed directly by HLA molecules, possibly by differences in expression levels or function.
pathology,immunology,cell biology
-
DNA Hyper-methylation Associated with Schizophrenia May Lead to Increased Levels of Autoantibodies
Hui Wei,Yanbo Yuan,Caiyun Zhu,Mingjie Ma,Fude Yang,Zheng Lu,Chuanyue Wang,Hong Deng,Jingping Zhao,Runhui Tian,Wanwan Zhu,Yan Shen,Xin Yu,Qi Xu
DOI: https://doi.org/10.1093/schizbullopen/sgac047
2022-01-01
Schizophrenia Bulletin Open
Abstract:Background and Hypothesis:Environmental stressors may influence immune surveillance in B lymphocytes and stimulate autoimmune responses via epigenetic DNA methylation modifications in schizophrenia (SCZ). Study Design:A total of 2722, Chinese Han origin subjects were recruited in this study (2005-2011), which included a discovery follow-up cohort with 40 remitters of SCZ (RSCZ), 40 nonremitters of SCZ (NRSCZ), and 40 controls (CTL), and a replication follow-up cohort (64 RSCZ, 16 NRSCZ, and 84 CTL), as well as a case-control validation cohort (1230 SCZ and 1208 CTL). Genomic DNA methylation, target gene mRNA transcripts, and plasma autoantibody levels were measured across cohorts. Study Results:We found extensive differences in global DNA methylation profiles between RSCZ and NRSCZ groups, wherein differential methylation sites (DMS) were enriched with immune cell maturation and activation in the RSCZ group. Out of 2722 participants, the foremost DMS cg14341177 was hyper-methylated in the SCZ group and it inhibited the alternative splicing of its target gene BICD2 and may have increased its autoantigen exposure, leading to an increase in plasma anti-BICD2 IgG antibody levels. The levels of cg14341177 methylation and anti-BICD2 IgG decreased significantly in RSCZ endpoint samples but not in NRSCZ endpoint samples. There are strong positive correlations between cg14341177 methylation, anti-BICD2 IgG, and positive and negative syndrome scale (PANSS) scores in the RSCZ groups, but not in the NRSCZ groups. Conclusions:These data suggest that abnormal DNA methylation could affect autoreactive responses in SCZ, and that cg14341177 methylation and anti-BICD2 IgG levels may potentially serve as useful biomarkers.
-
DNA hypermethylation in disease: mechanisms and clinical relevance
Melanie Ehrlich
DOI: https://doi.org/10.1080/15592294.2019.1638701
2019-07-08
Epigenetics
Abstract:Increasing numbers of studies implicate abnormal DNA methylation in cancer and many non-malignant diseases. This is consistent with numerous findings about differentiation-associated changes in DNA methylation at promoters, enhancers, gene bodies, and sites that control higher-order chromatin structure. Abnormal increases or decreases in DNA methylation contribute to or are markers for cancer formation and tumour progression. Aberrant DNA methylation is also associated with neurological diseases, immunological diseases, atherosclerosis, and osteoporosis. In this review, I discuss DNA hypermethylation in disease and its interrelationships with normal development as well as proposed mechanisms for the origin of and pathogenic consequences of disease-associated hypermethylation. Disease-linked DNA hypermethylation can help drive oncogenesis partly by its effects on cancer stem cells and by the CpG island methylator phenotype (CIMP); atherosclerosis by disease-related cell transdifferentiation; autoimmune and neurological diseases through abnormal perturbations of cell memory; and diverse age-associated diseases by age-related accumulation of epigenetic alterations.
genetics & heredity,biochemistry & molecular biology
-
Dnmt3a restrains mast cell inflammatory responses
Cristina Leoni,Sara Montagner,Andrea Rinaldi,Francesco Bertoni,Sara Polletti,Chiara Balestrieri,Silvia Monticelli
DOI: https://doi.org/10.1073/pnas.1616420114
IF: 11.1
2017-02-06
Proceedings of the National Academy of Sciences
Abstract:Significance Methylation of genomic DNA is an epigenetic modification at the interface between genetic information and environmental stimuli underlying many phenotypic variations in the human population as well as the pathogenesis of complex diseases. Accordingly, mutations in the de novo DNA methyltransferase enzyme DNMT3A have been identified in a number of diseases, including mast cell-related disorders. However, the role of DNA methylation and DNMT3A in regulating mast cell physiology still needs to be elucidated. Here, we found that Dnmt3a plays a critical role in modulating mast cell responsiveness to acute and chronic stimulation, potentially implicating DNA methylation-mediated processes in all types of mast cell-related diseases.
-
Dna Hypomethylation Is Crucial For Apoptotic Dna To Induce Systemic Lupus Erythematosus-Like Autoimmune Disease In Sle-Non-Susceptible Mice
Z. K. Wen,W. Xu,L. Xu,Q. H. Cao,Y. Wang,Y. W. Chu,S. D. Xiong
DOI: https://doi.org/10.1093/rheumatology/kem275
2007-01-01
Rheumatology
Abstract:Objectives. Systemic lupus erythematosus (SLE) is characterized by serological presence of anti-double-stranded DNA (dsDNA) antibodies and its pathogenesis remains unclarified. Our previous work found that syngeneic activated lymphocyte-derived DNA (ALD-DNA) induced SLE-like autoimmune disease in the SLE-non-prone BALB/c mice. Here, the biological and chemical characteristics of the somatic DNA were focused upon to investigate their contribution to the autoimmunity induction to provide clues for the understanding of the pathogenesis of SLE in non-susceptible strains.Methods. Induction of anti-dsDNA antibodies, glomerulonephritis and proteinuria was evaluated in BALB/c mice after subcutaneous immunization with apoptotic DNA (annexin-V+) extracted from concanavalin A or UV-treated apoptotic splenocytes or necrotic DNA from necrotic splenocytes. The hypomethylated apoptotic DNA and the normal DNA were then methylated and demethylated, respectively, by CpG methylase or 5-azacytidine treatment to re-evaluate their immunogenicity in BALB/c mice.Results. It was apoptotic but not necrotic DNA that induced SLE-like autoimmune disease and the level of apoptotic DNA was associated with the level of anti-dsDNA antibodies. The apoptotic DNA exhibited significantly lower methylation levels than the normal DNA. Methylation of the hypomethylated apoptotic DNA significantly impaired its ability to induce anti-dsDNA antibodies and proteinuria, while demethylation of the normal or necrotic DNA endowed them with the immunogenicity to induce the SLE-like syndrome.Conclusions. Our study provides direct evidence showing that DNA hypomethylation is essential for apoptotic DNA to induce SLE-like autoimmune disease in non-susceptible mice, which may help in elucidating the pathogenesis of SLE.
-
M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics
Yurong Huang,Qiuyun Xue,Jun Chang,Yuting Wang,Chenglong Cheng,Suowen Xu,Xiao Wang,Chenggui Miao
DOI: https://doi.org/10.1186/s13075-023-03149-w
2023-10-02
Abstract:Background: N6-methyladenosine (m6A) methylation modification is involved in the regulation of various biological processes, including inflammation, antitumor, and antiviral immunity. However, the role of m6A modification in the pathogenesis of autoimmune diseases has been rarely reported. Methods: Based on a description of m6A modification and the corresponding research methods, this review systematically summarizes current insights into the mechanism of m6A methylation modification in autoimmune diseases, especially its contribution to rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Results: By regulating different biological processes, m6A methylation is involved in the pathogenesis of autoimmune diseases and provides a promising biomarker for the diagnosis and treatment of such diseases. Notably, m6A methylation modification is involved in regulating a variety of immune cells and mitochondrial energy metabolism. In addition, m6A methylation modification plays a role in the pathological processes of RA, and m6A methylation-related genes can be used as potential targets in RA therapy. Conclusions: M6A methylation modification plays an important role in autoimmune pathological processes such as RA and SLE and represents a promising new target for clinical diagnosis and treatment, providing new ideas for the treatment of autoimmune diseases by targeting m6A modification-related pathways.